Skip to main content
SpringerLink
Log in

FDA highlights risk of benzonatate cough capsules in young children

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.FDA Says Tessalon Liquid Cough Capsules Pose Risk for Young Children. Media Release: 14 Dec 2010. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA highlights risk of benzonatate cough capsules in young children. React. Wkly. 1333, 3 (2011). https://doi.org/10.2165/00128415-201113330-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113330-00007

Keywords

Search

Navigation